The Advanced Microscopy Facility (AMF) is a matrix Cancer Center shared resource, which operates under the auspices of the Office of Research Core Administration, a department within the University of Virginia (UVA) School of Medicine (SOM). Since the first Cancer Center Support Grant to UVA in 1987, the AMF has provided Cancer Center investigators with unique access to instrumentation and services for visualization of biological processes and structures. As microscopy has become an indispensable and near universal tool for biomedical research, access to cutting edge microscopy equipment at the AMF has allowed Cancer Center members to make important discoveries regarding the cause, spread, and treatment of cancer. The AMF's primary mission is to serve the imaging needs and enable the exceptional cancer research at the University of Virginia.
The specific aims are to house and provide affordable access to state-of-the-art microscopy instrumentation and high-quality imaging services, empower Cancer Center investigators in the practice and science of imaging, and built a nexus for collaboration among the AMF users. The facility, which is both a full-service and a user-facility, has been expanded from primarily an electron microscopy center to now encompass a full range of light and electron microscopy technologies. The SOM has continued to support the AMF and since the last CCSG review and has made substantial investment (~$7 million) to establish the cryo-microscopy services. The institutional support and funds from NIH shared instrumentation grants have allowed the AMF to acquire an impressive array of state-of-the-art microscopes, including three confocal microscopes with super-resolution or two-photon imaging capabilities, and a 300 kV Titan Krios transmission electron microscope equipped with a direct electron detector, available at only a handful North American institutions. Providing Cancer Center members with access to electron cryo- microscopy services is a major advancement of the AMF's capabilities. The facility was rated ?outstanding? in the last review. The AMF staff have worked to further enhance the capabilities of the shared resource to provide exceptional services to Cancer Center researchers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA044579-26
Application #
9209265
Study Section
Special Emphasis Panel (NCI (E3)-A)
Project Start
Project End
Budget Start
2017-02-01
Budget End
2018-01-31
Support Year
26
Fiscal Year
2017
Total Cost
$51,326
Indirect Cost
$18,841
Name
University of Virginia
Department
Type
Domestic Higher Education
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Wang, T Tiffany; Yang, Jun; Zhang, Yong et al. (2018) IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective ?-chain cytokines, decreases leukemic T-cell viability. Leukemia :
Yao, Nengliang; Zhu, Xi; Dow, Alan et al. (2018) An exploratory study of networks constructed using access data from an electronic health record. J Interprof Care :1-8
Kiran, Shashi; Dar, Ashraf; Singh, Samarendra K et al. (2018) The Deubiquitinase USP46 Is Essential for Proliferation and Tumor Growth of HPV-Transformed Cancers. Mol Cell 72:823-835.e5
Conaway, Mark R; Petroni, Gina R (2018) The Impact of Early-Phase Trial Design in the Drug Development Process. Clin Cancer Res :
Szlachta, Karol; Kuscu, Cem; Tufan, Turan et al. (2018) CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response. Nat Commun 9:4275
Khalil, Shadi; Delehanty, Lorrie; Grado, Stephen et al. (2018) Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor. J Exp Med 215:661-679
Olmez, Inan; Zhang, Ying; Manigat, Laryssa et al. (2018) Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma. Cancer Res 78:4360-4369
Parini, Paolo; Melhuish, Tiffany A; Wotton, David et al. (2018) Overexpression of transforming growth factor ? induced factor homeobox 1 represses NPC1L1 and lowers markers of intestinal cholesterol absorption. Atherosclerosis 275:246-255
Banizs, Anna B; Huang, Tao; Nakamoto, Robert K et al. (2018) Endocytosis Pathways of Endothelial Cell Derived Exosomes. Mol Pharm :
Jia, Deshui; Augert, Arnaud; Kim, Dong-Wook et al. (2018) Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition. Cancer Discov 8:1422-1437

Showing the most recent 10 out of 539 publications